Arbutus Biopharma Corp

ABUS

$5.12

+0.39%

N/A+$0.02

Healthcare

Biotechnology

NASDAQ

Active Trading

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus ...

Insider Transactions of ABUS

Acquisitions (A)

Since Mar 31, 2025

Disposals (D)

Since Mar 31, 2025

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Jun 8, 2026	Sawhney Roger	director	Stock Option (Right to Buy)	A	78,800	$4.24
Jun 8, 2026	Beardsley Robert A	director	Stock Option (Right to Buy)	A	78,800	$4.24
Feb 2, 2026	Nguyen Tuan	officer: Chief Financial Officer	Stock Option (Right to Buy)	A	188,400	$4.39
Feb 2, 2026	Nguyen Tuan	officer: Chief Financial Officer	Common Shares	A	73,500	—
Feb 2, 2026	Androski Lindsay	director, officer: President and CEO	Stock Option (Right to Buy)	A	71,700	$4.39

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

2,176,800

Total Shares Sold

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

Androski Lindsay

director, officer: President and CEO • 2 txns

Nguyen Tuan

officer: Chief Financial Officer • 4 txns

Sawhney Roger

director • 3 txns

Beardsley Robert A

director • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Jun 8, 2026	Sawhney Roger	director	Stock Option (Right to Buy)	A	78,800	$4.24	$334,112.00
Jun 8, 2026	Beardsley Robert A	director	Stock Option (Right to Buy)	A	78,800	$4.24	$334,112.00
Feb 2, 2026	Nguyen Tuan	officer: Chief Financial Officer	Stock Option (Right to Buy)	A	188,400	$4.39	$827,076.00
Feb 2, 2026	Nguyen Tuan	officer: Chief Financial Officer	Common Shares	A	73,500	—	—
Feb 2, 2026	Androski Lindsay	director, officer: President and CEO	Stock Option (Right to Buy)	A	71,700	$4.39	$314,763.00
Feb 2, 2026	Androski Lindsay	director, officer: President and CEO	Common Shares	A	28,000	—	—
Aug 4, 2025	Sawhney Roger	director	Stock Option (Right to Buy)	A	157,600	$3.34	$526,384.00
Aug 4, 2025	Sawhney Roger	director:	—	—	0	—	—
Mar 31, 2025	Nguyen Tuan	officer: Chief Financial Officer	Stock Option (Right to Buy)	A	750,000	$3.49	$2,617,500.00
Mar 31, 2025	Nguyen Tuan	officer: Chief Financial Officer	Stock Option (Right to Buy)	A	750,000	$3.50	$2,625,000.00

Upstream

Genevant Sciences Ltd.Third-Party CDMOs (Drug Substance & Drug Product Manufacturing)X-Chem Inc.Proteros biostructures GmbHLipid Excipient Manufacturers (CordenPharma, Merck KGaA, etc.)Oligonucleotide Raw Material Suppliers

Downstream

Moderna, Inc.NASDAQ:MRNA Alnylam Pharmaceuticals, Inc.NASDAQ:ALNY Barinthus Biotherapeutics plcNASDAQ:BRNS Roivant Sciences Ltd.NASDAQ:ROIVAcuitas Therapeutics Inc.Qilu Pharmaceutical Co., Ltd.Gritstone bio, Inc. (fka Gritstone Oncology)

Proxies

Alnylam Pharmaceuticals, Inc.NASDAQ:ALNY Moderna, Inc.NASDAQ:MRNA Roivant Sciences Ltd.NASDAQ:ROIV Barinthus Biotherapeutics plcNASDAQ:BRNS Gilead Sciences, Inc.NASDAQ:GILD

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

Arbutus Biopharma Corp

Insider Transactions of ABUS

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of ABUS

Upstream

Downstream

Proxies

Insider Transactions of ABUS

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of ABUS

Upstream

Downstream

Proxies